These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4388267)

  • 41. Clindamycin (Dalacin C).
    Drug Ther Bull; 1970 Aug; 8(17):67-8. PubMed ID: 5480245
    [No Abstract]   [Full Text] [Related]  

  • 42. [Empyema: bacterial epidemiology and antibiotic resistance].
    Vu-Thien H
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S81-3. PubMed ID: 19000860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nitrofuryl heterocyclics. 3.
    Islip PJ; Johnson MR
    J Med Chem; 1973 Nov; 16(11):1308-10. PubMed ID: 4147838
    [No Abstract]   [Full Text] [Related]  

  • 44. [Antibiotic therapy].
    Schmid F; Haus E; Schreiber A
    Fortschr Med; 1973 Apr; 91(10):430-4 contd. PubMed ID: 4700410
    [No Abstract]   [Full Text] [Related]  

  • 45. Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogens.
    Or YS; Clark RF; Wang S; Chu DT; Nilius AM; Flamm RK; Mitten M; Ewing P; Alder J; Ma Z
    J Med Chem; 2000 Mar; 43(6):1045-9. PubMed ID: 10737737
    [No Abstract]   [Full Text] [Related]  

  • 46. [Tetracycline resistance in beta-hemolytic streptococci and pneumococci].
    Pulverer G
    Dtsch Med Wochenschr; 1967 Sep; 92(36):1608-12. PubMed ID: 4383130
    [No Abstract]   [Full Text] [Related]  

  • 47. Synthesis and antibacterial activity of N4-mono alkyl derivatives of novel glycopeptide LYV07ww01.
    Shao C; Zhou W; Zhang S; Wei W; Ruan L; Jin Y; Sun X; Huang Y
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6732-8. PubMed ID: 21978682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Studies on josamycin. 3. (1) Bacteriological studies. (2) Protective effect against infections due to pathogenic bacteria. (3) Absorption, excretion, distribution in organs and in vivo activities].
    Osono T; Yano K; Mitamoto F; Watanabe S; Ishida H
    Jpn J Antibiot; 1969 Apr; 22(2):159-72. PubMed ID: 4389777
    [No Abstract]   [Full Text] [Related]  

  • 49. [Sensitivity to antibiotics of bacterial flora isolated under aerobic conditions in cases of acute odontogenic perimaxillary inflammation].
    Wizimirska J; Lewandowski B
    Wiad Lek; 1984 Mar; 37(6):423-9. PubMed ID: 6485325
    [No Abstract]   [Full Text] [Related]  

  • 50. In vitro and in vivo evaluation of enduracidin, a new peptide antibiotic substance.
    Goto S; Kuwahara S; Okubo N; Zenyoji H
    J Antibiot (Tokyo); 1968 Feb; 21(2):119-25. PubMed ID: 4299887
    [No Abstract]   [Full Text] [Related]  

  • 51. [Antibiotic activity of the methacycline-triacetyl-oleandomycin association].
    Ambrosoli G; Ciarlini E; Lazzarini L
    Antibiotica; 1966 Sep; 4(3):169-89. PubMed ID: 4384277
    [No Abstract]   [Full Text] [Related]  

  • 52. Recent Updates on the Role of Pharmacokinetics-pharmacodynamics in Antimicrobial Susceptibility Testing as Applied to Clinical Practice.
    Labreche MJ; Graber CJ; Nguyen HM
    Clin Infect Dis; 2015 Nov; 61(9):1446-52. PubMed ID: 26105168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic-resistance in Streptococcus pneumoniae.
    Krisher K
    Adv Exp Med Biol; 1995; 390():123-40. PubMed ID: 8718608
    [No Abstract]   [Full Text] [Related]  

  • 54. CEPHALOTHIN--A NEW ANTIBIOTIC. PRELIMINARY CLINICAL AND LABORATORY STUDIES.
    GRIFFITH RS; BLACK HR
    JAMA; 1964 Sep; 189():823-8. PubMed ID: 14172279
    [No Abstract]   [Full Text] [Related]  

  • 55. [Antibiotic resistance of streptococci pneumococci and some gram-negative bacilli isolated from patients in the years 1962-1967 in the Katowice province].
    Szaflarski J; Urbańska L; Rogala D; Holowiecka D; Kapp Z; Sedlaczek A
    Przegl Epidemiol; 1970; 24(3):313-7. PubMed ID: 4394822
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparative bacteriological investigations with the combination trimethoprim/sulfamethoxazole in vitro and in vivo].
    Böhni E
    Chemotherapy; 1969; 14():Suppl:1-21. PubMed ID: 4908562
    [No Abstract]   [Full Text] [Related]  

  • 57. [Various prospective approaches to the treatment of nonspecific lung diseases].
    Sil'vestrov VP; Vanina NF
    Ter Arkh; 1980; 52(3):3-12. PubMed ID: 6966837
    [No Abstract]   [Full Text] [Related]  

  • 58. [Experiences with lincomycin from the clinic and laboratory].
    Vacek V; Hejzlar M
    Arzneimittelforschung; 1966 Dec; 16(12):1600-6. PubMed ID: 4385186
    [No Abstract]   [Full Text] [Related]  

  • 59. [Antibiotic microbial resistance surveillance in invasive infections caused by Streptococcus pneumoniae and Staphylococcus aureus: the EARSS (European Antimicrobial Resistance Surveillance System) project in Italy (April 1999-April 2000)].
    Moro ML; Pantosti A; Boccia D;
    Ann Ig; 2002; 14(5):361-71. PubMed ID: 12508445
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alfa-6-deoxy-oxy-tetracycline in the treatment of pyogenic infections of skin.
    Chuttani CS; Saxena SN; Pal SC; Chuttani HK
    Chemotherapy; 1969; 14(2):101-8. PubMed ID: 5807483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.